EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Abbott India Ltd.

ABBOTINDIA

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

NSE: ABBOTINDIAOfficial website ↗

Key metrics

Market Cap

₹54,865 cr

P/E Ratio

35.97x

P/B Ratio

12.96x

ROE

33.41%

ROCE

42.85%

Debt / Equity

0.05x

Net Margin

22.08%

Dividend Yield

184%

EPS

₹665.62

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 75.56%FII: 7.80%Public: 16.64%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Abbott India Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.